Two more clinical laboratory organizations that used American Medical Collection Agency (AMCA) to handle their lab test claims announced in July that their patients’ data was breached. Inform Diagnostics of Irving, Texas, disclosed that the data of 173,716 patients was compromised. Within days of that announcement, CompuNet Clinical Laboratories of Moraine, Ohio, stated that about 110,000 of its patients had data exposed by the data breach at AMCA. Both lab companies said they have stopped doing business with AMCA.
MORE ON: Data Breach
Among the first laboratory companies to publicly disclose that their patients’ data had been compromised by a breach at AMCA were BioReference Laboratories, LabCorp, and Quest Diagnostics. (See TDR, June 10, 2019.) According to the HIPAA Journal, AMCA has told 20 or more companies that their patient data have been exposed by the breach, and at least 24,390,307 patients were notified that their data was compromised.
- The Indiana Business Journal reported that Jack J. Philips, currently CEO of Roche Diagnostics North America, is leaving the company as of August 31. He will become CEO of Accelerate Diagnostics, of Tucson, Ariz. Philips previously held positions at Ventana Medical Systems and Chiron Diagnostics.
- Pathologist Donald A.B. Lindberg, MD, FACMI, 85 years old, died on August 17, 2019, at his home in Columbia, Missouri. Before retiring, he was the Director of the National Library of Medicine for more than 30 years. Lindberg is recognized as pioneering the application of computer technology in healthcare beginning in 1960 when he was at the University of Missouri.
- Ortho-Clinical Diagnostics announced the appointment of Chris Smith as its new Chief Executive Officer, effective Sept. 9. Smith formerly held executive positions at Cochlear Limited, Warburg Pincus, and Gyrus Group Plc.
- Ortho-Clinical Diagnostics also stated that Robert Yates, currently OCD’s President, will step down from that role and continue to serve on the company’s board as non-Executive Chairman. Yates came to OCD in 2014 and previously served at Merck KGaA’s EMD/Merck Millipore division, and Roche Diagnostics.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, September 23, 2019.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…the excitement over multiple researchers at different organizations reporting progress on identifying biomarkers that could be used to accurately diagnose Alzheimer’s Disease. Several research teams presented papers on their biomarkers at the Alzheimer’s Association International Conference in July.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.